| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |